Department of Internal Medicine, Division of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, The Netherlands.
Mol Genet Metab. 2012 Jun;106(2):135-41. doi: 10.1016/j.ymgme.2012.03.010. Epub 2012 Mar 24.
Previous studies have explicitly shown that small nerve fibers are affected in Fabry disease which is assumed to cause the severe neuropathic pain that patients may have from childhood on. Neuropathic pain and small fiber neuropathy characteristics have therefore been considered as appropriate study endpoints in studies on the efficacy of enzyme replacement therapy. However, the relationship between small fiber neuropathy characteristics and pain, as well as the course of small fiber neuropathy in Fabry disease is still uncertain. In this article a comprehensive overview of the existing literature on small nerve fiber function and structure and the relationship with pain, age and disease severity is presented supplemented with data from the Dutch Fabry cohort, with the aim to identify consensus as well as controversies and to propose a hypothesis on the evolution of neuropathy in Fabry disease.
先前的研究已经明确表明,法布瑞氏病会影响小神经纤维,这被认为是导致患者从儿童时期就可能出现严重神经病理性疼痛的原因。因此,神经病理性疼痛和小纤维神经病特征已被认为是评估酶替代疗法疗效研究的适当终点。然而,小纤维神经病特征与疼痛之间的关系以及法布瑞氏病中小纤维神经病的病程仍不确定。本文综合了现有关于小神经纤维功能和结构以及与疼痛、年龄和疾病严重程度关系的文献综述,并补充了荷兰法布瑞氏病队列的数据,旨在确定共识以及争议,并提出法布瑞氏病神经病演变的假说。